Skip to main content
Clinical Trials/CTRI/2021/07/034970
CTRI/2021/07/034970
Not yet recruiting
未知

Evaluation of services being provided at Health and Wellness Centre of bhavnagar district. - NA

Dr Kartik B Prajapati0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Kartik B Prajapati
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Dr Kartik B Prajapati

Eligibility Criteria

Inclusion Criteria

  • All HWCs fulfilling the inclusion criteria (for evaluation of services)
  • 30 CHO from the selected HWCs (for time motion study)

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Hope for chronically suicidal patient: evaluating the clinical and health services impact of dialectical behaviour therapy (DBT) in individuals with borderline personality disorder
ISRCTN02634417The Centre for Addiction and Mental Health (Toronto) (Canada)180
Completed
Not Applicable
Study to evaluate health care situation and quality of life in patients with registered anti-VEGF treatment in neovascular AMD, diabetic macular edema or retinal vein occlusioPatients with neovascular AMD or visual impairment due to diabetic macular edema or visual impairment due to retinal vein occlusion.H34.8H35.3H35.8Other retinal vascular occlusionsDegeneration of macula and posterior poleOther specified retinal disorders
DRKS00010267ovartis Pharma GmbH3,224
Completed
Not Applicable
Evaluation of the quality of supply of patients with PAD (intermittent claudication) stage II in GermanyI73.9Peripheral vascular disease, unspecified
DRKS00004964Klinik für Kardiologie und Angiologie IUniversitäts-Herzzentrum Freiburg Bad-Krozingen628
Completed
Not Applicable
Healthcare Evaluation and Assessment of Patients with Chronic Fatigue Syndrome (CFS)Chronic Fatigue SyndromeMental and Behavioural DisordersMyalgic encephalomyelitis
ISRCTN31455243The Gatsby Foundation (UK)60
Active, not recruiting
Not Applicable
An audit of clinical service delivery and outcomes using Tumour Necrosis Factor Inhibition therapy (- a Biological agent that targets inflammation) for the treatment of Diffuse Idiopathic Skeletal Hyperostosis (a condition where calcification of ligaments, tendons and joint capsule insertions in the spine causes pain, stiffness and restricted movements).Diffuse idiopathic skeletal hyperostosisHyperostosis
ACTRN12617001299392Dr Graeme Carroll65